FDA Inspection 1214688 — Dendreon Pharmaceuticals LLC

Dendreon Pharmaceuticals LLC — FEI 3008821247

The FDA completed an inspection of Dendreon Pharmaceuticals LLC on Aug 10, 2023 in Seal Beach, CA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 2 citations were issued during this inspection. Product area: Biologics.

Inspection details

Classification
Voluntary Action Indicated (VAI)
End Date
Aug 10, 2023
Fiscal Year
2023
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
Seal Beach, CA (United States)

Citations

IDCFRDescription
185121 CFR 211.84(e)Rejecting When Specifications Not Met
202821 CFR 211.192Extent of discrepancy, failure investigations

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.